Qiwei Wu

1.6k total citations · 2 hit papers
39 papers, 960 citations indexed

About

Qiwei Wu is a scholar working on General Health Professions, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Qiwei Wu has authored 39 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in General Health Professions, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Clinical Psychology. Recurrent topics in Qiwei Wu's work include Patient-Provider Communication in Healthcare (11 papers), COVID-19 and Mental Health (5 papers) and Diabetes Treatment and Management (5 papers). Qiwei Wu is often cited by papers focused on Patient-Provider Communication in Healthcare (11 papers), COVID-19 and Mental Health (5 papers) and Diabetes Treatment and Management (5 papers). Qiwei Wu collaborates with scholars based in United States, China and South Korea. Qiwei Wu's co-authors include Mark L. Hartman, Lee M. Kaplan, Axel Haupt, Yu Du, Juan P. Frías, Ania M. Jastreboff, Tamer Coskun, Sirel Gurbuz, Zvonko Miličević and Jianguo Sun and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Qiwei Wu

37 papers receiving 948 citations

Hit Papers

Triple–Hormone-Receptor Agonist Retatrutide for Obesity —... 2023 2026 2024 2025 2023 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
    2023 549 citations Lee M. Kaplan, Juan P. Frías et al. profile →
  2. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
    2024 118 citations Arun J. Sanyal, Lee M. Kaplan et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiwei Wu United States 11 472 278 239 156 142 39 960
Curtis J. Rosebraugh United States 16 588 1.2× 237 0.9× 212 0.9× 281 1.8× 279 2.0× 24 1.3k
Rodolfo J. Galindo United States 25 1.5k 3.2× 60 0.2× 181 0.8× 186 1.2× 496 3.5× 115 2.1k
Arran Shearer United Kingdom 10 480 1.0× 48 0.2× 240 1.0× 85 0.5× 85 0.6× 21 1.0k
Kelly Bell United States 15 387 0.8× 39 0.1× 59 0.2× 110 0.7× 74 0.5× 36 741
Luigi Meneghini United States 29 2.6k 5.5× 101 0.4× 160 0.7× 462 3.0× 990 7.0× 113 3.1k
Justin Northrup United States 14 1.2k 2.5× 338 1.2× 105 0.4× 503 3.2× 427 3.0× 17 1.6k
Ian Peacock United Kingdom 15 532 1.1× 45 0.2× 88 0.4× 137 0.9× 185 1.3× 33 1.0k
Carlos Alatorre United States 11 150 0.3× 44 0.2× 63 0.3× 82 0.5× 37 0.3× 18 625
Jonathan G. Levine United States 7 48 0.1× 145 0.5× 76 0.3× 34 0.2× 49 0.3× 8 615
Xi Cheng United States 16 460 1.0× 200 0.7× 83 0.3× 106 0.7× 294 2.1× 32 1.0k

Countries citing papers authored by Qiwei Wu

Since Specialization
Citations

This map shows the geographic impact of Qiwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiwei Wu more than expected).

Fields of papers citing papers by Qiwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiwei Wu. The network helps show where Qiwei Wu may publish in the future.

Co-authorship network of co-authors of Qiwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiwei Wu. A scholar is included among the top collaborators of Qiwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiwei Wu. Qiwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Qiwei, et al.. (2025). Where Can Artificial Intelligence Assist Cancer Care?: Examining Patient‐Centered Communication Dimension Effects. Health Services Research. 61(2). e14653–e14653. 1 indexed citations
3.
4.
Kaplan, Lee M., Carel W. le Roux, David J. Hunter, et al.. (2025). Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials. Diabetes Obesity and Metabolism. 28(1). 83–93.
5.
Coskun, Tamer, Qiwei Wu, Nanette C. Schloot, et al.. (2025). Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial. The Lancet Diabetes & Endocrinology. 13(8). 674–684. 3 indexed citations
6.
7.
Wu, Qiwei, et al.. (2024). Two sides of trust: How cancer survivors’ communication with healthcare providers and on social media predicted healthy behaviors during COVID-19. Patient Education and Counseling. 131. 108553–108553. 1 indexed citations
8.
9.
Sanyal, Arun J., Lee M. Kaplan, Juan P. Frías, et al.. (2024). Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature Medicine. 30(7). 2037–2048. 118 indexed citations breakdown →
10.
Wu, Qiwei, et al.. (2023). Enhanced ionic conductivity of composite solid electrolyte by defective Li1.3Al0.3Ti1.7(PO4-y)3 for solid-state Li-ion batteries. Ceramics International. 50(7). 10137–10143. 9 indexed citations
11.
Li, Xiaoshan, et al.. (2023). Information-Seeking Behavior for COVID-19 Boosters in China: A Cross-Sectional Survey. Vaccines. 11(2). 323–323. 1 indexed citations
12.
Wu, Qiwei, et al.. (2023). Health-oriented leadership communication matters: a trickle-down model to enhance employees' health and well-being during turbulent times. Corporate Communications An International Journal. 29(3). 384–404. 5 indexed citations
13.
14.
Wu, Qiwei, et al.. (2023). What’s after COVID-19?: Communication pathways influencing future use of telehealth. Patient Education and Counseling. 118. 108025–108025. 4 indexed citations
15.
Wu, Qiwei, et al.. (2022). Factors related to moderate exercise during COVID-19 for overweight and obese individuals: A secondary analysis of HINTS data. SHILAP Revista de lepidopterología. 1. 100058–100058. 2 indexed citations
16.
Wu, Qiwei, Xiyuan Liu, & Elaine J. Yuan. (2021). Debating the Two-child Policy on Sina Weibo: A Study of Social Media as Symbolic Space in China. Journal of Broadcasting & Electronic Media. 65(5). 699–723. 3 indexed citations
17.
Wu, Qiwei, Hui Zhao, Liang Zhu, & Jianguo Sun. (2020). Variable selection for high‐dimensional partly linear additive Cox model with application to Alzheimer's disease. Statistics in Medicine. 39(23). 3120–3134. 16 indexed citations
18.
Zhao, Hui, Qiwei Wu, Peter B. Gilbert, Ying Qing Chen, & Jianguo Sun. (2020). A regularized estimation approach for case‐cohort periodic follow‐up studies with an application to HIV vaccine trials. Biometrical Journal. 62(5). 1176–1191. 7 indexed citations
19.
Wu, Qiwei & Richard L. Street. (2020). Factors affecting cancer patients’ electronic communication with providers: Implications for COVID-19 induced transitions to telehealth. Patient Education and Counseling. 103(12). 2583–2587. 17 indexed citations
20.
Zhang, Yu‐Dong, Ping Jing, Qiwei Wu, et al.. (2017). Bulk self-assembly and ionic conductivity of a block copolymer containing an azobenzene-based liquid crystalline polymer and a poly(ionic liquid). Polymer Chemistry. 8(10). 1689–1698. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Curtis J. Rosebraugh Breakdown of academic impact, for papers by Rodolfo J. Galindo Breakdown of academic impact, for papers by Arran Shearer Breakdown of academic impact, for papers by Kelly Bell Breakdown of academic impact, for papers by Luigi Meneghini Breakdown of academic impact, for papers by Justin Northrup Breakdown of academic impact, for papers by Ian Peacock Breakdown of academic impact, for papers by Carlos Alatorre Breakdown of academic impact, for papers by Jonathan G. Levine Breakdown of academic impact, for papers by Xi Cheng
Rankless by CCL
2026